Digital Health November 17, 2022
A partnership between Novo Nordisk and Abbott means people living with diabetes can now better review their glucose patterns to help manage the condition.
Novo Nordisk’s smart connected pens are now compatible with the Abbott FreeStyle LibreLink app. The integration means that diabetic patients using the NovoPen 6 or the NovoPen Echo Plus are able to view both their insulin dosing data and their glucose data together in one place.
To automatically upload their insulin dosing data, users can tap the pen against their smart phone. Once the data is uploaded it can be viewed alongside their glucose data to help diabetics review how different factors like dose timing and amount of insulin can impact their glucose patterns.
Su Down,...
Today's Sponsors
Today's Sponsor